| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 60.5148 | 65 |
| GSM780708 | Untreated after 4 days (C2_1) | 64.0006 | 67 |
| GSM780709 | Untreated after 4 days (C3_1) | 71.6143 | 70 |
| GSM780719 | Untreated after 4 days (C1_2) | 55.0079 | 59 |
| GSM780720 | Untreated after 4 days (C2_2) | 73.2229 | 70 |
| GSM780721 | Untreated after 4 days (C3_2) | 76.7827 | 71 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 68.2183 | 68 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 67.2632 | 68 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 65.1016 | 67 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 71.3718 | 69 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 61.2374 | 65 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 66.5114 | 68 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.5706 | 59 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 62.895 | 66 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.0754 | 49 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 53.3813 | 57 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 57.0831 | 62 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 60.9424 | 65 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 70.6741 | 69 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 77.1979 | 71 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 64.0006 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 78.9843 | 71 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 71.7674 | 70 |